| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activator activity | 3.71e-06 | 10 | 64 | 3 | GO:0016176 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 6.77e-06 | 12 | 64 | 3 | GO:0016175 | |
| GeneOntologyMolecularFunction | benzoate-CoA ligase activity | 3.03e-05 | 3 | 64 | 2 | GO:0018858 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 3.44e-05 | 20 | 64 | 3 | GO:0050664 | |
| GeneOntologyMolecularFunction | decanoate-CoA ligase activity | 6.04e-05 | 4 | 64 | 2 | GO:0102391 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 1.91e-04 | 35 | 64 | 3 | GO:0043325 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 2.80e-04 | 8 | 64 | 2 | GO:0004321 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid-CoA ligase activity | 5.46e-04 | 11 | 64 | 2 | GO:0031956 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 7.71e-04 | 13 | 64 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | GTPase inhibitor activity | 7.71e-04 | 13 | 64 | 2 | GO:0005095 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 9.92e-04 | 238 | 64 | 5 | GO:0016747 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ADCY10 TRIM49 CPA6 USP5 PRDM9 SETMAR MGAT1 TIMP2 POLE TRIM49C ALOXE3 | 1.29e-03 | 1189 | 64 | 11 | GO:0046914 |
| GeneOntologyMolecularFunction | histone binding | 1.60e-03 | 265 | 64 | 5 | GO:0042393 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of gram-positive bacterium | 2.84e-07 | 5 | 64 | 3 | GO:0070946 | |
| GeneOntologyBiologicalProcess | NADP catabolic process | 9.88e-07 | 7 | 64 | 3 | GO:0006742 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of fungus | 9.88e-07 | 7 | 64 | 3 | GO:0070947 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle contraction | 4.11e-06 | 35 | 64 | 4 | GO:0045932 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst involved in inflammatory response | 4.62e-06 | 11 | 64 | 3 | GO:0060264 | |
| GeneOntologyBiologicalProcess | reactive oxygen species biosynthetic process | 4.93e-06 | 80 | 64 | 5 | GO:1903409 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in inflammatory response | 7.97e-06 | 13 | 64 | 3 | GO:0002536 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of bacterium | 1.55e-05 | 16 | 64 | 3 | GO:0070944 | |
| GeneOntologyBiologicalProcess | response to yeast | 2.25e-05 | 18 | 64 | 3 | GO:0001878 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of symbiont cell | 2.66e-05 | 19 | 64 | 3 | GO:0070943 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in defense response | 3.13e-05 | 20 | 64 | 3 | GO:0002679 | |
| GeneOntologyBiologicalProcess | neutrophil mediated cytotoxicity | 3.64e-05 | 21 | 64 | 3 | GO:0070942 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle contraction | 4.21e-05 | 22 | 64 | 3 | GO:0045986 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide biosynthetic process | 4.21e-05 | 22 | 64 | 3 | GO:0050665 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst | 4.83e-05 | 23 | 64 | 3 | GO:0060263 | |
| GeneOntologyBiologicalProcess | killing by host of symbiont cells | 2.22e-04 | 38 | 64 | 3 | GO:0051873 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 2.79e-04 | 41 | 64 | 3 | GO:0006691 | |
| GeneOntologyBiologicalProcess | respiratory burst | 3.22e-04 | 43 | 64 | 3 | GO:0045730 | |
| GeneOntologyBiologicalProcess | neutrophil mediated immunity | 4.46e-04 | 48 | 64 | 3 | GO:0002446 | |
| GeneOntologyBiologicalProcess | superoxide anion generation | 5.03e-04 | 50 | 64 | 3 | GO:0042554 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | 5.72e-04 | 767 | 64 | 9 | GO:0055086 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 2.16e-05 | 18 | 64 | 3 | GO:0043020 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 2.15e-04 | 96 | 64 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 6.60e-04 | 129 | 64 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | Swr1 complex | 7.04e-04 | 13 | 64 | 2 | GO:0000812 | |
| MousePheno | increased angiotensin I-converting enzyme activity | 1.14e-06 | 6 | 55 | 3 | MP:0003184 | |
| MousePheno | abnormal angiotensin I-converting enzyme activity | 1.14e-06 | 6 | 55 | 3 | MP:0013254 | |
| MousePheno | liver abscess | 1.99e-06 | 7 | 55 | 3 | MP:0003332 | |
| MousePheno | abnormal circulating renin level | 4.73e-06 | 29 | 55 | 4 | MP:0003349 | |
| MousePheno | impaired granulocyte bactericidal activity | 6.78e-06 | 10 | 55 | 3 | MP:0005074 | |
| MousePheno | decreased susceptibility to Orthomyxoviridae infection | 4.51e-05 | 18 | 55 | 3 | MP:0020947 | |
| MousePheno | abnormal Purkinje cell dendrite morphology | 7.77e-05 | 58 | 55 | 4 | MP:0008572 | |
| MousePheno | decreased vasoconstriction | 8.42e-05 | 22 | 55 | 3 | MP:0003026 | |
| MousePheno | single kidney | 9.48e-05 | 61 | 55 | 4 | MP:0003604 | |
| MousePheno | increased circulating renin level | 9.65e-05 | 23 | 55 | 3 | MP:0003352 | |
| MousePheno | oxidative stress | 3.19e-04 | 152 | 55 | 5 | MP:0003674 | |
| MousePheno | impaired smooth muscle contractility | 3.45e-04 | 35 | 55 | 3 | MP:0000740 | |
| MousePheno | granulomatous inflammation | 3.75e-04 | 36 | 55 | 3 | MP:0002500 | |
| MousePheno | abnormal redox activity | 5.78e-04 | 173 | 55 | 5 | MP:0003186 | |
| Domain | AMP-bd_C | 1.38e-03 | 17 | 61 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 1.38e-03 | 17 | 61 | 2 | PF13193 | |
| Domain | RNaseH-like_dom | 1.49e-03 | 69 | 61 | 3 | IPR012337 | |
| Domain | CTCK_1 | 1.55e-03 | 18 | 61 | 2 | PS01185 | |
| Domain | PLAT | 2.12e-03 | 21 | 61 | 2 | PS50095 | |
| Domain | - | 2.12e-03 | 21 | 61 | 2 | 2.60.60.20 | |
| Domain | PLAT | 2.12e-03 | 21 | 61 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 2.12e-03 | 21 | 61 | 2 | IPR001024 | |
| Domain | CT | 2.32e-03 | 22 | 61 | 2 | SM00041 | |
| Domain | Cys_knot_C | 3.00e-03 | 25 | 61 | 2 | IPR006207 | |
| Domain | CTCK_2 | 3.00e-03 | 25 | 61 | 2 | PS01225 | |
| Domain | AMP-binding_CS | 3.24e-03 | 26 | 61 | 2 | IPR020845 | |
| Domain | AMP_BINDING | 3.76e-03 | 28 | 61 | 2 | PS00455 | |
| Domain | AMP-binding | 4.30e-03 | 30 | 61 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 4.30e-03 | 30 | 61 | 2 | IPR000873 | |
| Domain | ConA-like_dom | 5.70e-03 | 219 | 61 | 4 | IPR013320 | |
| Domain | SET | 7.93e-03 | 41 | 61 | 2 | PF00856 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES | 3.92e-06 | 9 | 52 | 3 | MM14524 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 1.03e-04 | 25 | 52 | 3 | MM15269 | |
| Pathway | REACTOME_CONJUGATION_OF_SALICYLATE_WITH_GLYCINE | 1.98e-04 | 6 | 52 | 2 | MM14693 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 2.61e-04 | 34 | 52 | 3 | MM1399 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 2.77e-04 | 7 | 52 | 2 | MM14598 | |
| Pathway | REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES | 2.85e-04 | 35 | 52 | 3 | MM14944 | |
| Pathway | REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES | 3.65e-04 | 38 | 52 | 3 | MM14519 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 4.73e-04 | 9 | 52 | 2 | M26968 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 6.43e-04 | 46 | 52 | 3 | MM15837 | |
| Pubmed | 1.04e-11 | 4 | 64 | 4 | 35838051 | ||
| Pubmed | Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. | 1.04e-11 | 4 | 64 | 4 | 27798263 | |
| Pubmed | 5.20e-11 | 5 | 64 | 4 | 24272050 | ||
| Pubmed | 1.56e-10 | 6 | 64 | 4 | 33349630 | ||
| Pubmed | 1.56e-10 | 6 | 64 | 4 | 27397585 | ||
| Pubmed | 1.56e-10 | 6 | 64 | 4 | 28515366 | ||
| Pubmed | 3.63e-10 | 7 | 64 | 4 | 29434374 | ||
| Pubmed | Memory CD8+ T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes. | 7.26e-10 | 8 | 64 | 4 | 17698589 | |
| Pubmed | Developmental expression of NADPH phagocytic oxidase components in mouse embryos. | 1.30e-09 | 9 | 64 | 4 | 10447107 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 18036262 | ||
| Pubmed | Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. | 5.94e-09 | 3 | 64 | 3 | 10678931 | |
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 5.94e-09 | 3 | 64 | 3 | 27044504 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 17167081 | ||
| Pubmed | Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors. | 5.94e-09 | 3 | 64 | 3 | 24358335 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 10891396 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 25474113 | ||
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 5.94e-09 | 3 | 64 | 3 | 18787174 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 26209274 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 24873968 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 22184329 | ||
| Pubmed | NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. | 5.94e-09 | 3 | 64 | 3 | 11018074 | |
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 5.94e-09 | 3 | 64 | 3 | 33545139 | |
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 5.94e-09 | 3 | 64 | 3 | 20142487 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 9116268 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 20686129 | ||
| Pubmed | Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. | 5.94e-09 | 3 | 64 | 3 | 21570954 | |
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 5.94e-09 | 3 | 64 | 3 | 25565313 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 39357591 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 12958309 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 11435342 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 31118934 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 23482812 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 16041040 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 10085000 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 10987289 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 21435178 | ||
| Pubmed | Intermittent hypoxia has organ-specific effects on oxidative stress. | 5.94e-09 | 3 | 64 | 3 | 18703411 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 29228045 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 17307863 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 22155727 | ||
| Pubmed | Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. | 5.94e-09 | 3 | 64 | 3 | 27829407 | |
| Pubmed | Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction. | 5.94e-09 | 3 | 64 | 3 | 24576409 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 22376231 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 23918780 | ||
| Pubmed | NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. | 5.94e-09 | 3 | 64 | 3 | 28274989 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 26645958 | ||
| Pubmed | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. | 5.94e-09 | 3 | 64 | 3 | 12364355 | |
| Pubmed | NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. | 5.94e-09 | 3 | 64 | 3 | 24549323 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 34557202 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 28467721 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 10670582 | ||
| Pubmed | NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. | 5.94e-09 | 3 | 64 | 3 | 20881184 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 26528554 | ||
| Pubmed | The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. | 5.94e-09 | 3 | 64 | 3 | 19052348 | |
| Pubmed | Effect of early particulate air pollution exposure on obesity in mice: role of p47phox. | 5.94e-09 | 3 | 64 | 3 | 20864666 | |
| Pubmed | Reactive oxygen species delay control of lymphocytic choriomeningitis virus. | 5.94e-09 | 3 | 64 | 3 | 23328631 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 34572995 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 17114280 | ||
| Pubmed | Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. | 5.94e-09 | 3 | 64 | 3 | 19168575 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 25989352 | ||
| Pubmed | NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. | 5.94e-09 | 3 | 64 | 3 | 19503084 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 17404617 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 17332431 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 36592568 | ||
| Pubmed | Genetic requirement of p47phox for superoxide production by murine microglia. | 5.94e-09 | 3 | 64 | 3 | 11156938 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 30504842 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 10772875 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 27798190 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 20702812 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 33705493 | ||
| Pubmed | Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. | 5.94e-09 | 3 | 64 | 3 | 23965970 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 26455429 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 15513930 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 15626477 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 15033459 | ||
| Pubmed | NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity. | 5.94e-09 | 3 | 64 | 3 | 19077231 | |
| Pubmed | Neutrophil-derived ROS contribute to oxidative DNA damage induction by quartz particles. | 5.94e-09 | 3 | 64 | 3 | 20828610 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 20817944 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 22319452 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 16895801 | ||
| Pubmed | Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. | 5.94e-09 | 3 | 64 | 3 | 20690191 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 16772302 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 32504071 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 16280459 | ||
| Pubmed | Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. | 5.94e-09 | 3 | 64 | 3 | 18185592 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 36853827 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 23024271 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 21253614 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 25873172 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 15310853 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 31393787 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 10725280 | ||
| Pubmed | Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice. | 5.94e-09 | 3 | 64 | 3 | 34970267 | |
| Pubmed | Germ-free mice deficient of reactive oxygen species have increased arthritis susceptibility. | 5.94e-09 | 3 | 64 | 3 | 25689796 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 14993144 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 22050439 | ||
| Pubmed | The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. | 5.94e-09 | 3 | 64 | 3 | 12031896 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 11249873 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 15936744 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 17220182 | ||
| Cytoband | 7q11.23 | 3.47e-04 | 97 | 64 | 3 | 7q11.23 | |
| Cytoband | 3q25.1 | 9.82e-04 | 33 | 64 | 2 | 3q25.1 | |
| Cytoband | 16p12.3 | 1.04e-03 | 34 | 64 | 2 | 16p12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q14 | 1.38e-03 | 156 | 64 | 3 | chr11q14 | |
| Cytoband | 12p13 | 3.65e-03 | 64 | 64 | 2 | 12p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p11 | 6.34e-03 | 85 | 64 | 2 | chr12p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 6.50e-03 | 271 | 64 | 3 | chr7q11 | |
| GeneFamily | Acyl-CoA synthetase family | 1.81e-03 | 26 | 44 | 2 | 40 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_25_PRECICTIVE_ICB_RESPONSE | 1.85e-05 | 225 | 64 | 6 | MM17079 | |
| Coexpression | GAVIN_PDE3B_TARGETS | 3.07e-05 | 25 | 64 | 3 | MM726 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_DN | 4.03e-05 | 78 | 64 | 4 | M9911 | |
| Coexpression | HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 4.41e-05 | 159 | 64 | 5 | M40998 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.62e-06 | 183 | 64 | 5 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.97e-06 | 185 | 64 | 5 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.14e-06 | 191 | 64 | 5 | a143af67fc3270439f390edec599d2e3d29a107f | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.23e-06 | 196 | 64 | 5 | e4f40274df940e0996c555082f2bb4f99e5b0881 | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.93e-06 | 199 | 64 | 5 | 933201d32eda12a89660bdbae9114a95cc428a38 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.93e-06 | 199 | 64 | 5 | 0dde17381b8a95bfddb4d1052b13d33f37b05d13 | |
| ToppCell | Severe-Myeloid-Macrophages|Severe / Condition, Lineage, Cell class and cell subclass | 1.02e-05 | 200 | 64 | 5 | ee1d80fa5d4609f9a6b10c33950e888f509a063c | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.02e-05 | 200 | 64 | 5 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-05 | 200 | 64 | 5 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.80e-05 | 139 | 64 | 4 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | BLOOD--(3)_MNP-(3)_Classical_Mono-1|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.22e-05 | 142 | 64 | 4 | 395f80e99be4a0ef07fb9d65c74399e7e67c9a8d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.70e-05 | 162 | 64 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Tem/emra_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.91e-05 | 163 | 64 | 4 | 1a8c79903ed416f286ebe8a9922233affbc55d82 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.12e-05 | 164 | 64 | 4 | 057ca87847373eff7fe97dd9f4358509e66ca4c3 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.31e-05 | 61 | 64 | 3 | 5e855b5462f42b7a1d0bbd518cc11072342ce0cc | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.31e-05 | 61 | 64 | 3 | 2fc13475581431f82e0b5ef42e18cd29c9787666 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 169 | 64 | 4 | 2e15a9317da4017757d184f7cc91bd66b072ac51 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 170 | 64 | 4 | 46a81d505de845cc59f80594fce338f7fdb9250f | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 170 | 64 | 4 | 1a9a0487c35cf3fd5806d1f0f0e91ef0e0b9cd0a | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 170 | 64 | 4 | 830646815410c47e9bca8c9bae75dfc45c9c9b33 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 171 | 64 | 4 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 176 | 64 | 4 | d09e28606e2a6ed1f660898316765ca215085c18 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 183 | 64 | 4 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 183 | 64 | 4 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 184 | 64 | 4 | 61caaa31975e05c9a6512079c791fed5a9e2d39f | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 184 | 64 | 4 | 03da0f0f89f1ca5a3ccca1e22972f3129464e68e | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 184 | 64 | 4 | 9ed2a65a4ca0ebbbb89ace61027522f93369843d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 184 | 64 | 4 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-04 | 185 | 64 | 4 | ae53aa2ecfe418a5dbd7d963a995bc06dab94f56 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 185 | 64 | 4 | 9de1db2ce9e44956b1214daf6e1e161334679c88 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 185 | 64 | 4 | 18f5d9438c76e37988a7d17aa2a080af6bedbfc4 | |
| ToppCell | Control-B_naive-5|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.51e-04 | 187 | 64 | 4 | 8c48d67435e168edb892217b3f82c74f2dcedc14 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte|COVID-19_Convalescent / Disease condition and Cell class | 1.53e-04 | 72 | 64 | 3 | 73db21be480920fc936f3a965495f5cf004e350a | |
| ToppCell | Control-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.57e-04 | 189 | 64 | 4 | d39e112417a850f6e7b33315eab636fa90448301 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 190 | 64 | 4 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 190 | 64 | 4 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-04 | 191 | 64 | 4 | 361b123c8289015206d5e706ab2c615d9a724179 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.64e-04 | 191 | 64 | 4 | 7d00796459f4ff0ab7f06a8379b2d34e76b078b2 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.67e-04 | 192 | 64 | 4 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 192 | 64 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-04 | 193 | 64 | 4 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 193 | 64 | 4 | 3d254bc85187745ba41d86646bd4cc681a71d13e | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 193 | 64 | 4 | 891c0d4119a1c090b8230d00f9f69997850cab8c | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.74e-04 | 194 | 64 | 4 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.74e-04 | 194 | 64 | 4 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-04 | 195 | 64 | 4 | d53585715c7f5827c4f5a6db11cb31857ee9d4f0 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-04 | 195 | 64 | 4 | 3311a1bf4ed94820b45047d44fc14b14ac72e6fb | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.77e-04 | 195 | 64 | 4 | 19413dc6aa0010686cdfa0c750ef0a7a76caf308 | |
| ToppCell | distal-2-Endothelial-Lymphatic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.77e-04 | 195 | 64 | 4 | 8e0f67a67af3bc0b16f48a621f74540f136383b7 | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|myeloid / Lineage, cell class and subclass | 1.77e-04 | 195 | 64 | 4 | 15ba9c5f6ecb6ae2c603e6b036eb92b00b46f13f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-04 | 195 | 64 | 4 | de47651c84da62f273535fc80115f0154746699d | |
| ToppCell | distal-Endothelial-Lymphatic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.77e-04 | 195 | 64 | 4 | f45c1349932ee7eb419cced8a4fdedae3610953f | |
| ToppCell | metastatic_Brain-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 1.81e-04 | 196 | 64 | 4 | d1a2768a1d0e5928fbd9debb7dcd7436134e09f6 | |
| ToppCell | distal-Endothelial-Lymphatic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.81e-04 | 196 | 64 | 4 | 3e8a20e1d163dcbd3bbd99fe179d54af02298af0 | |
| ToppCell | URO-Myeloid-CD14_Mono|URO / Disease, Lineage and Cell Type | 1.84e-04 | 197 | 64 | 4 | 45c16125fa32e50304fdd45a7cb457488bd50ee3 | |
| ToppCell | severe_COVID-19-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.84e-04 | 197 | 64 | 4 | cdffd49db7374d223ded46d636cd4be12d464ea4 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.84e-04 | 197 | 64 | 4 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | 390C-Myeloid-Monocyte-CD14+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-04 | 197 | 64 | 4 | cd941c5ef76897047bd8508d98510c4ff164d223 | |
| ToppCell | Influenza_Severe-Classical_Monocyte|World / Disease group and Cell class | 1.84e-04 | 197 | 64 | 4 | e9a01f0fbbeaf6b23bce4603f62053c003848da4 | |
| ToppCell | T_cells-Treg_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.84e-04 | 197 | 64 | 4 | ec9398ae3577f61d6b1e6aba50ef4261aaaa7610 | |
| ToppCell | proximal-Hematologic-B_cell|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.84e-04 | 197 | 64 | 4 | 735b5026d28cd3677947ae8e462f6fd640cf9c9b | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.84e-04 | 197 | 64 | 4 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | proximal-Hematologic-B_cell-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.84e-04 | 197 | 64 | 4 | 08b3f2e3933242b9fa93998cfce3d094a3db833e | |
| ToppCell | proximal-3-Hematologic-B_cell|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.84e-04 | 197 | 64 | 4 | 81ba0eb2222e83b4ba2db3228dc04c390c2dbc63 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.84e-04 | 197 | 64 | 4 | 367aaf277c56962c96ddb4de06949fb33fc6170b | |
| ToppCell | control-Myeloid|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.88e-04 | 198 | 64 | 4 | abf08cde20c1843d54ba008c1db5a6ab376c761e | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.88e-04 | 198 | 64 | 4 | c7c5865395992131d0766a03c9c63bad9196b02f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-04 | 198 | 64 | 4 | d5c816fb894f55acbbab188e6262668acc422fb9 | |
| ToppCell | proximal-Hematologic-Classical_Monocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-04 | 198 | 64 | 4 | 6a7ca6eef6b74aa7fc3aec84e9ffd0beedaa589b | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.88e-04 | 198 | 64 | 4 | c4a004f211f72f28aacbb512c6e075cbd049be53 | |
| ToppCell | mild-Myeloid|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.88e-04 | 198 | 64 | 4 | 908746384e10c6b833bb3bc124045d7b0bfd73b5 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.88e-04 | 198 | 64 | 4 | c65103828a4755fcf3c0776c60d8ada1f0ad5278 | |
| ToppCell | 390C-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-04 | 198 | 64 | 4 | 36e49a4860b37d674511120b9e0366efa1e08480 | |
| ToppCell | severe-Myeloid|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.88e-04 | 198 | 64 | 4 | d19902a6353445f9875dec59933b7553f5145b8b | |
| ToppCell | proximal-3-Hematologic-Classical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-04 | 198 | 64 | 4 | 6c6a63b8ec03b7a8f46b70bf13261fab56355f92 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-04 | 198 | 64 | 4 | 6d547122b8c4ddbdd0d3dae3bce4a125740d5457 | |
| ToppCell | proximal-Hematologic-Classical_Monocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-04 | 198 | 64 | 4 | 98bd2b3e03ab659ce163d5773660ce008e4cc2ca | |
| ToppCell | Influenza_Severe-Classical_Monocyte|Influenza_Severe / Disease group and Cell class | 1.92e-04 | 199 | 64 | 4 | 077ace6e0faedb8c701fcb227427204678867237 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.92e-04 | 199 | 64 | 4 | 7cbd98dd10c91584dee04593910031e90c1340b8 | |
| ToppCell | BAL-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.92e-04 | 199 | 64 | 4 | 0f0fcc6fb980167cfa9aa404b845441fb95a08f4 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.92e-04 | 199 | 64 | 4 | 0e696f13c9bd135fbb31368d6dca29897d6a1a25 | |
| ToppCell | BAL-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.92e-04 | 199 | 64 | 4 | 3662ed5d929ab64293e65f33dabcefc3458a08e5 | |
| ToppCell | Mild-Myeloid-Macrophages|Mild / Condition, Lineage, Cell class and cell subclass | 1.92e-04 | 199 | 64 | 4 | d8a00e6aecc4bfd1f868f1ee54bcfa820401efaf | |
| ToppCell | Mild_COVID-19-Myeloid|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.92e-04 | 199 | 64 | 4 | c0a9f5629db5beff7c07c9d111a7707e062d746f | |
| ToppCell | BAL-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 1.92e-04 | 199 | 64 | 4 | 4518ffa51ead9da1ddf07bf048b18602e50f0f84 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid|LPS_only / Treatment groups by lineage, cell group, cell type | 1.92e-04 | 199 | 64 | 4 | 20523dee39a4c5f6423259920f108127b47525c4 | |
| ToppCell | Mild-Myeloid|Mild / Condition, Lineage, Cell class and cell subclass | 1.92e-04 | 199 | 64 | 4 | 0678e50ffda664fb76681a1ee9021deab73bf850 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1+SPP1+|Mild / Condition, Lineage, Cell class and cell subclass | 1.92e-04 | 199 | 64 | 4 | 2cbaef86af870a228cb46895dd765ea8894c83c5 | |
| ToppCell | severe_influenza-Classical_Monocyte|severe_influenza / disease group, cell group and cell class (v2) | 1.92e-04 | 199 | 64 | 4 | 899d9fa9e3d97e876da27674de89c33bff1affe9 | |
| ToppCell | 390C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-04 | 199 | 64 | 4 | 1a691dbf3da26f5450bde428a7c886dbc4834c81 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.95e-04 | 200 | 64 | 4 | bc56d6d6d32405685e9bd553ebdbe48b8fbe6902 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-04 | 200 | 64 | 4 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Severe-Myeloid|Severe / Condition, Lineage, Cell class and cell subclass | 1.95e-04 | 200 | 64 | 4 | 77ae7b037226d479b37077d20a3cc150da251900 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 1.95e-04 | 200 | 64 | 4 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | BAL-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-04 | 200 | 64 | 4 | bb246c630b2fde1633b28838a5f087fdfb4bc4a5 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 200 | 64 | 4 | 35bbd3fc96c4f249bd79c4c5ad8ee6eb6df32c33 | |
| ToppCell | Sepsis-URO-Myeloid-CD14+_Monocyte|URO / Disease, condition lineage and cell class | 1.95e-04 | 200 | 64 | 4 | 209976dbbfc1edbeb3ea128cd0453ec9572f54cb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.95e-04 | 200 | 64 | 4 | 5f1de1f9305e1784c12d526f6c8bdd7d56229f9b | |
| ToppCell | Influenza-Influenza_Severe-Myeloid|Influenza_Severe / Disease, condition lineage and cell class | 1.95e-04 | 200 | 64 | 4 | 2bf931ec2c6165698ba600b151fd30d8dd921d95 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-NPM1P10|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.95e-04 | 200 | 64 | 4 | 7b3284bf0000e14f5a51e4422231e5639a184579 | |
| Drug | tesaglitazar | 9.56e-07 | 502 | 62 | 10 | ctd:C501413 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 8.81e-08 | 5 | 62 | 3 | DOID:3265 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 1.92e-06 | 12 | 62 | 3 | DOID:7148 (implicated_via_orthology) | |
| Disease | X-21319 measurement | 4.34e-06 | 2 | 62 | 2 | EFO_0800807 | |
| Disease | X-11478 measurement | 1.30e-05 | 3 | 62 | 2 | EFO_0021242 | |
| Disease | 3-hydroxyhexanoate measurement | 4.33e-05 | 5 | 62 | 2 | EFO_0800378 | |
| Disease | gamma-enolase measurement | 6.48e-05 | 6 | 62 | 2 | EFO_0021845 | |
| Disease | indoleacetoylcarnitine measurement | 6.48e-05 | 6 | 62 | 2 | EFO_0800106 | |
| Disease | REM sleep behavior disorder | 6.48e-05 | 6 | 62 | 2 | EFO_0007462 | |
| Disease | matrix metalloproteinase measurement | 3.34e-04 | 13 | 62 | 2 | EFO_0004744 | |
| Disease | psychosis | 3.89e-04 | 14 | 62 | 2 | EFO_0005407 | |
| Disease | X-24309 measurement | 8.05e-04 | 20 | 62 | 2 | EFO_0800872 | |
| Disease | phosphatidylinositol measurement | 1.07e-03 | 95 | 62 | 3 | EFO_0010230 | |
| Disease | urinary uromodulin measurement | 1.10e-03 | 96 | 62 | 3 | EFO_0005663 | |
| Disease | Adenoid Cystic Carcinoma | 1.24e-03 | 100 | 62 | 3 | C0010606 | |
| Disease | migraine disorder, pulse pressure measurement | 1.37e-03 | 26 | 62 | 2 | EFO_0005763, MONDO_0005277 | |
| Disease | uridine measurement | 2.07e-03 | 32 | 62 | 2 | EFO_0010546 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WVNGKGKELMWNFRE | 71 | Q08AH3 | |
| NFMCLWQSCKKWFQT | 1631 | Q68CP9 | |
| NILEKCWLNMNKESW | 1546 | Q96PN6 | |
| FKNCDLMWKQSIWTS | 101 | P09417 | |
| NRNWKVKWCDEGASM | 271 | Q8N4T0 | |
| DMMGKVDVWKWCNLS | 46 | O60896 | |
| WMEWDKQGCTGKLQR | 201 | Q8IXQ6 | |
| WKTDGKWQRDMCNVL | 96 | Q17RR3 | |
| ISLANWMCLAKWESG | 41 | P61626 | |
| WCVSAWNDNGKEQMV | 236 | P26572 | |
| DMPFAKWTKEQVCNW | 641 | Q86W92 | |
| KWTKEQVCNWLMEQG | 646 | Q86W92 | |
| GSWKKLDDMQNIFWC | 241 | Q9BYJ1 | |
| SSNWKLFKECWKQGQ | 2176 | Q15652 | |
| EKWGWIMFECGLENL | 1886 | Q2LD37 | |
| LMQAMWKCAQETAWD | 456 | Q9BPX6 | |
| CFIAMLETWWNKRKG | 846 | O43424 | |
| VEKSESGWWFCQMKA | 186 | P14598 | |
| AKWDACANMKVWLFE | 311 | Q6P1A2 | |
| NIFKLWGWTMLCCDF | 16 | P14151 | |
| ANCQRKMAWQWRGEF | 661 | Q07864 | |
| KWWNVLPGNMKTSCF | 441 | A8MWY0 | |
| NCNKPRWEKWFMVTF | 466 | Q9HC58 | |
| VVEKSESGWWFCQMK | 186 | A6NI72 | |
| VVEKSESGWWFCQMK | 161 | A8MVU1 | |
| GSWQHWCQLTFKKLM | 246 | Q86VF5 | |
| DGKDKSWANWMRYVN | 306 | Q9NQV7 | |
| NEGSFKWKMLWITSC | 321 | O95389 | |
| KKCQVLWMEGWSNSS | 2801 | Q8NCM8 | |
| FWNQGLTWKVLFCSM | 271 | P51797 | |
| YRNMERNWKWACKSL | 466 | P34913 | |
| PSKWWTCFVKRQFMN | 156 | O15145 | |
| SQEMKCILHWFANWS | 36 | Q9NWQ9 | |
| KDKQMDFCWDPWQRC | 46 | Q96AQ9 | |
| DCLKLWLMWKAQGDQ | 361 | Q9Y600 | |
| ELWTKGMLNAKTRCW | 996 | O75165 | |
| LWCPTTENMDKDGKW | 151 | Q96BH3 | |
| KSFIQKKMQNWCPSW | 121 | Q9BY44 | |
| KKMQNWCPSWSEDET | 126 | Q9BY44 | |
| QEFNSTWAWEMEKKG | 96 | Q96T23 | |
| MKWCWVDEAGVICKQ | 436 | Q9Y2H2 | |
| LWQLFFDMSQWKQCC | 411 | Q9BST9 | |
| WNWAFGVCNMYRKEK | 351 | P0CI25 | |
| MQTGYNKLCDWWSLG | 296 | Q9Y2H1 | |
| ANERTVQWWFKKFCK | 381 | Q53H47 | |
| AEWWKQAGLNLKMME | 361 | Q5VXU9 | |
| SLDWWITDKCNMING | 236 | Q14108 | |
| NWEMELKRWCPSFKI | 681 | Q6ZRS2 | |
| QEKRGEHLSWLCMFW | 286 | Q7L0J3 | |
| ELMEKDLCVKGWNWG | 96 | Q08945 | |
| WVNGKGKELMWNFRE | 71 | Q68CK6 | |
| NPWWAAFSRVCKDMN | 321 | Q03154 | |
| ADGWRWKIMIANANK | 441 | O14967 | |
| KGNNWWAQSVELCKK | 1516 | P53675 | |
| NNVCAKKMDWTGSIW | 251 | Q96S66 | |
| AIDWGKMAEQWLQEK | 1671 | Q7KZ85 | |
| MGQCRNWKWGLESFD | 1 | P0CG00 | |
| FWVIQGETDFCMSKW | 341 | Q5GH72 | |
| VTDLRDVKCSGNWMW | 756 | O15067 | |
| DVKCSGNWMWAAKLP | 761 | O15067 | |
| WNWAFGVCNMYRKEK | 351 | P0CI26 | |
| ECLWMDWVTEKNING | 171 | P16035 | |
| LYCDCNMQWLSDWVK | 861 | O94813 | |
| MLGIMAWNATCKNWL | 1 | Q9BXA5 | |
| EMACQGHKWALKALW | 826 | Q14679 | |
| QNWEAMGNHFWIKQC | 2481 | Q9Y4A5 | |
| QEEDMWAGLWQKRCK | 2756 | Q9Y4A5 | |
| GWKCSKCDMRENLWL | 196 | P45974 | |
| MTDAASCGSEVKKWW | 1706 | Q8IZF0 |